Applied Therapeutics, Inc.
APLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $455 | $9,993 | $0 | $0 |
| % Growth | -95.4% | – | – | – |
| Cost of Goods Sold | $48,744 | $53,905 | $441 | $0 |
| Gross Profit | -$48,289 | -$43,912 | -$441 | $0 |
| % Margin | -10,613% | -439.4% | – | – |
| R&D Expenses | $48,744 | $53,905 | $55,634 | $62,570 |
| G&A Expenses | $55,461 | $20,118 | $27,316 | $42,543 |
| SG&A Expenses | $56,010 | $20,623 | $27,316 | $43,048 |
| Sales & Mktg Exp. | $549 | $505 | $0 | $505 |
| Other Operating Expenses | -$48,744 | -$53,905 | -$441 | $0 |
| Operating Expenses | $56,010 | $20,623 | $82,509 | $105,618 |
| Operating Income | -$104,299 | -$64,535 | -$82,950 | -$105,618 |
| % Margin | -22,922.9% | -645.8% | – | – |
| Other Income/Exp. Net | -$1,325 | -$55,228 | $442 | $34 |
| Pre-Tax Income | -$105,624 | -$119,763 | -$82,508 | -$105,584 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$105,624 | -$119,763 | -$82,508 | -$105,584 |
| % Margin | -23,214.1% | -1,198.5% | – | – |
| EPS | -0.76 | -1.42 | -2.18 | -4.12 |
| % Growth | 46.5% | 34.9% | 47.1% | – |
| EPS Diluted | -0.76 | -1.42 | -2.18 | -4.12 |
| Weighted Avg Shares Out | 139,535 | 84,244 | 37,825 | 25,598 |
| Weighted Avg Shares Out Dil | 139,535 | 84,244 | 37,825 | 25,598 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,534 | $1,372 | $685 | $555 |
| Interest Expense | $0 | $0 | $0 | $555 |
| Depreciation & Amortization | $1 | $1 | $441 | $1 |
| EBITDA | -$104,298 | -$64,534 | -$82,067 | -$105,617 |
| % Margin | -22,922.6% | -645.8% | – | – |